Efficacy and Safety of Treatment With Ferric Carboxymaltose in Patients With Cirrhosis and Gastrointestinal Bleeding

Background: Patients with liver cirrhosis and gastrointestinal bleeding (GIB) often develop anemia. Ferric carboxymaltose (FCM) is an intravenous (i.v.) iron formulation approved for use in patients with iron deficiency with inadequate response to oral iron therapy or when oral iron cannot be used....

Descripción completa

Detalles Bibliográficos
Autores principales: Ballester-Clau, Raquel, Torres Vicente, Gisela, Cucala Ramos, Mercedes, Aracil Blanch, Carles, Miñana Calafat, Josep Maria, Pijoan Comas, Eva, Reñé Espinet, Josep Maria, Planella de Rubinat, Montse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181670/
https://www.ncbi.nlm.nih.gov/pubmed/32363194
http://dx.doi.org/10.3389/fmed.2020.00128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181670/
https://www.ncbi.nlm.nih.gov/pubmed/32363194
http://dx.doi.org/10.3389/fmed.2020.00128

Ejemplares similares